StockNews.com Begins Coverage on Mannatech (NASDAQ:MTEX)

Research analysts at StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX) in a report released on Friday. The firm set a “buy” rating on the stock.

Mannatech Price Performance

Shares of Mannatech stock opened at $7.53 on Friday. The stock has a market capitalization of $14.18 million, a price-to-earnings ratio of -8.46 and a beta of 1.17. Mannatech has a twelve month low of $6.75 and a twelve month high of $10.51. The company has a current ratio of 1.17, a quick ratio of 0.62 and a debt-to-equity ratio of 0.54. The business’s 50 day simple moving average is $7.58 and its 200-day simple moving average is $7.58.

Mannatech (NASDAQ:MTEX) last issued its earnings results on Tuesday, August 13th. The company reported ($0.33) earnings per share for the quarter. The company had revenue of $27.74 million during the quarter. Mannatech had a negative return on equity of 11.87% and a negative net margin of 0.97%.

Insiders Place Their Bets

In other news, Director Larry A. Jobe sold 16,288 shares of Mannatech stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $7.75, for a total transaction of $126,232.00. Following the sale, the director now owns 54,721 shares of the company’s stock, valued at approximately $424,087.75. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 41.50% of the stock is owned by insiders.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.